Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bromodomain-containing protein family comprises proteins that possess at least one bromodomain, a conserved structural motif that specifically recognizes and binds to acetylated lysine residues, primarily on histone tails. Through this recognition, bromodomain-containing proteins act as "readers" of epigenetic marks and play crucial roles in regulating gene expression by facilitating chromatin remodeling and transcriptional activation or repression. They are classified into families like BET and non-BET proteins, with diverse functions in cell proliferation, differentiation, DNA damage repair, and oncogenesis. Different bromodomain subfamilies exhibit distinct histone recognition specificities. The family members are central regulators in epigenetics due to their ability to interpret lysine acetylation signals on histones—a key mechanism underlying dynamic changes in gene expression during development and disease states such as cancer.
Binding to acetylated lysine residues on histones, thereby modulating gene transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bromodomain-Containing Protein Family (BRD).